Colorectal cancerMACA CANCER INFORMATION GUIDE
Understanding colorectal cancer.
What colorectal (bowel) cancer is, the changes to look out for, how screening can prevent it or find it early, how it is diagnosed and staged, and the treatments your care team may discuss with you.
What is colorectal cancer?
Colorectal cancer is cancer that starts in the colon or the rectum. It is also called bowel cancer, and you may hear it described as colon cancer or rectal cancer depending on where it begins. It starts when cells in the lining of the bowel grow out of control and form a tumour.
The colon and rectum
The colon and rectum together make up the large bowel (large intestine), the last part of the digestive system. The colon is a long, muscular tube that absorbs water and salt from digested food. The rectum is the last part of the bowel, about 15 cm long. It stores stool (poo) until it leaves the body through the anus.
Polyps
Most colorectal cancers begin as polyps, small growths on the inner lining of the bowel. Polyps are common, especially with age, and most never become cancer. But some types, called adenomas, can slowly turn into cancer over several years. Larger polyps, having several polyps and polyps with abnormal-looking cells carry a higher risk. Finding and removing polyps before they change is one of the main ways colorectal cancer can be prevented.
How common is colorectal cancer?
Colorectal cancer is the third most common cancer in the world and the second leading cause of cancer deaths. The World Health Organization estimates that in 2022 about 1.9 million people were diagnosed with it and more than 900,000 died from it.
In Africa, an analysis of GLOBOCAN 2022 estimates found about 70,000 new cases in 2022, and colorectal cancer was among the four most commonly diagnosed cancers in more than half of African countries. If current rates continue, the number of new cases each year in Africa is expected to more than double, to about 169,000 by 2050, partly because populations are growing and ageing.
Younger adults are affected too
Colorectal cancer mostly affects people over 50, but it is not only a disease of older people. A 2025 review of studies from 24 African countries found that about 38% of people diagnosed with colorectal cancer were under 50, and about 21% were under 40. Young age is not a reason to ignore bowel symptoms.
Signs and symptoms
Early colorectal cancer often causes no symptoms, or only mild ones. Changes to look out for include:
- Blood in your stool, which may look bright red or dark and tar-like, or bleeding from your bottom
- A change in your usual bowel habits that lasts for weeks, such as diarrhoea, constipation, or needing to go more or less often
- Stools that are narrower than usual
- Feeling that you need to open your bowels even after you have just been
- Tummy (abdominal) pain, cramps, bloating or a lump in the tummy that does not go away
- Losing weight without trying
- Tiredness, weakness or breathlessness. Slow bleeding from the bowel can cause anaemia (a low red blood cell count)
These symptoms are often caused by more common conditions, such as haemorrhoids (piles), infections or other bowel problems. Because of this, colorectal cancer is sometimes mistaken for something else, and people may be treated for piles or an infection for months before the real cause is found. In a 2025 study in Nigeria, the median time from first noticing symptoms to a cancer diagnosis was 12 months across the cancers studied, which included colorectal cancer.
Risk factors
Anyone can develop colorectal cancer. Having a risk factor does not mean you will get it, and many people who do have no obvious risk factor. Things that increase the risk include:
- Age: the risk rises markedly after the age of 50, although younger adults can be affected.
- Family history: having a parent, brother, sister or child who has had colorectal cancer, especially if they were diagnosed before 50.
- Inherited conditions: such as Lynch syndrome and familial adenomatous polyposis (FAP), which run in families and greatly increase the risk, often at a younger age.
- Personal history: having had colorectal cancer or certain types of polyp before.
- Inflammatory bowel disease: long-standing ulcerative colitis or Crohn’s disease affecting the colon.
- Diet: eating a lot of red and processed meat and few fruits and vegetables.
- Weight and activity: being overweight or obese and not being physically active.
- Alcohol and tobacco: drinking alcohol and smoking both increase the risk.
- Type 2 diabetes: is linked with a higher risk.
Screening and early detection
Screening means testing people who have no symptoms. For colorectal cancer, screening does two things: it can find cancer early, when it is easier to treat, and it can find polyps so they can be removed before they ever become cancer. Screening has been shown to reduce both the number of people who get colorectal cancer and the number who die from it.
Stool tests
Stool tests look for signs of cancer in a small sample of stool, which you can usually collect at home.
- Faecal immunochemical test (FIT): checks for tiny amounts of blood that cannot be seen. It is simple and is usually repeated every year.
- Stool DNA tests: look for blood and for changes in DNA from cancer or polyp cells. They are used every three years where available.
A positive stool test does not mean you have cancer. It means you need a colonoscopy soon to find the cause.
Colonoscopy
In a colonoscopy, a doctor passes a thin, flexible tube with a light and camera (a colonoscope) through the anus to look at the whole of the colon and rectum. You take a strong laxative beforehand to empty the bowel, and you are usually given medicine to help you relax. If polyps are found, they can usually be removed during the same test (a polypectomy) and sent to the laboratory. If the colonoscopy is normal, it is usually not repeated for ten years in people at average risk.
Who should consider screening?
Recommendations differ between countries and depend on what is available. The American Cancer Society advises people at average risk to start regular screening at 45 and to continue to 75 if they are in good health. People at higher risk, for example because of a strong family history, an inherited condition or inflammatory bowel disease, may be advised to start earlier and be checked more often.
Organised screening programmes are not yet available in many African countries. Ask your doctor whether screening is right for you, which test is available near you and how often you should have it. Because many people in Africa are diagnosed before 50, researchers have suggested that screening here may need to start at a younger age.
Types of colorectal cancer
By type of cell
- Adenocarcinoma: starts in the cells that make mucus to line the bowel. It is by far the most common type of colorectal cancer. Some less common subtypes, such as mucinous and signet ring cell adenocarcinoma, may behave differently.
- Neuroendocrine (carcinoid) tumours: start in hormone-making cells in the bowel. They are much less common.
- Other rare types: include gastrointestinal stromal tumours (GISTs), lymphomas and sarcomas. These are treated differently from adenocarcinoma.
By where the cancer starts
Colon cancer and rectal cancer are closely related and are often grouped together. But where the cancer is matters for treatment. Rectal cancer sits in the narrow space of the pelvis, close to the anus, so it is more often treated with radiotherapy and needs particular care during surgery to protect bowel control.
By what the cancer cells carry
Tests on the cancer cells look for particular changes that help guide treatment:
- Mismatch repair (MMR) or microsatellite instability (MSI): shows whether the cells have a fault in the system that repairs DNA. Cancers with this fault (called dMMR or MSI-high) often respond well to immunotherapy. The result can also be a sign of Lynch syndrome, an inherited condition.
- RAS and BRAF genes: changes in these genes affect which targeted medicines may work for advanced cancer.
Diagnosis
If you have symptoms, your doctor will ask about your health, your bowel habits and your family history, and examine you. This may include a digital rectal examination, in which the doctor gently feels inside the rectum with a gloved finger. They may then arrange the following tests.
Looking inside the bowel
A colonoscopy, which looks at the whole colon and rectum, is the main test for diagnosing colorectal cancer. Sometimes a shorter test called a sigmoidoscopy is used to look at the rectum and lower colon.
Biopsy
A biopsy is the only sure way to diagnose colorectal cancer. During a colonoscopy or sigmoidoscopy, small samples of tissue are taken and examined under a microscope. The pathology report describes the type of cancer, how abnormal the cells look (the grade) and the results of tests such as MMR or MSI.
Blood tests
Blood tests check for anaemia and show how well your liver and kidneys are working. A test for CEA (carcinoembryonic antigen), a substance that can be raised in colorectal cancer, helps to monitor treatment and check for the cancer coming back, but it cannot diagnose cancer on its own.
Checking for spread
Scans show how far the cancer has grown and whether it has spread. A CT scan of the chest, abdomen and pelvis is commonly used. For rectal cancer, an MRI scan of the pelvis shows the tumour and nearby tissues in detail and helps plan treatment. Other scans, such as PET-CT, may be used in some situations.
Stages and outlook
The stage describes how deeply the cancer has grown into the bowel wall, whether it has reached nearby lymph nodes and whether it has spread to other parts of the body (TNM).
- Stage 0: abnormal cells are found only in the innermost lining of the bowel (carcinoma in situ).
- Stage I: the cancer has grown into the deeper layers of the bowel wall but has not spread to lymph nodes.
- Stage II: the cancer has grown through the wall of the bowel and may have reached nearby tissues or organs, but has not spread to lymph nodes.
- Stage III: the cancer has spread to nearby lymph nodes.
- Stage IV: the cancer has spread to other parts of the body, most often the liver or lungs, or to the lining of the abdomen (metastatic colorectal cancer).
Outlook
The outlook depends strongly on the stage at diagnosis. In the United States, about 90–91% of people whose colon or rectal cancer is found before it has spread beyond the bowel are alive five years later. This falls to about 74% when it has spread to nearby tissues or lymph nodes, and to about 13–18% when it has spread to distant organs. These figures come from people diagnosed between 2014 and 2020 with good access to treatment. Outcomes in Africa are often lower because cancer is more often found late. Your care team can explain what your stage means for you.
Treatment
Treatment depends on where the cancer is, its stage, the results of tests on the cancer cells, your general health and your own preferences. A team that may include surgeons, oncologists, radiologists, pathologists, specialist nurses and stoma nurses plans it with you. Many people have more than one type of treatment.
Surgery
Surgery is the main treatment for most colorectal cancers that have not spread.
- Polypectomy or local excision: very early cancers in a polyp, or small early rectal cancers, may be removed during a colonoscopy or through the anus, without opening the abdomen.
- Colectomy or resection: the part of the bowel containing the cancer is removed, together with nearby lymph nodes. The two healthy ends are then joined back together (an anastomosis).
- Surgery for rectal cancer: needs particular care to remove the cancer while protecting the nerves and muscles that control the bowel and bladder. If the cancer is very close to the anus, the rectum and anus may need to be removed.
- Surgery for spread: when cancer has spread to a small number of places in the liver or lungs, these may sometimes be removed or destroyed with heat or cold (ablation).
Stomas
Sometimes the ends of the bowel cannot be joined, or need time to heal. The surgeon then brings part of the bowel out through an opening on the tummy, called a stoma. Stool passes out through the stoma into a bag worn over it. A stoma made from the colon is called a colostomy; one made from the small bowel is called an ileostomy.
Many stomas are temporary and can be closed in a later operation, once the bowel has healed. A stoma is permanent when the rectum and anus have been removed. Ask your team before surgery whether you are likely to need a stoma and whether it may be temporary or permanent.
Chemotherapy
Chemotherapy uses medicines to kill cancer cells throughout the body. Medicines such as fluorouracil (5-FU), capecitabine, oxaliplatin and irinotecan are given by drip or as tablets. Chemotherapy is usually offered after surgery for stage III colon cancer, and sometimes for stage II, to lower the risk of the cancer coming back. It is also used to shrink or control cancer that has spread.
Radiotherapy for rectal cancer
Radiotherapy uses high-energy rays to destroy cancer cells. It is mainly used for rectal cancer, often together with chemotherapy (chemoradiotherapy), before surgery. This can shrink the tumour, make it easier to remove and lower the chance of it coming back in the pelvis. Sometimes a shorter course of radiotherapy is given instead. For some people whose cancer disappears completely after chemoradiotherapy, the team may suggest close monitoring (“watch and wait”) instead of surgery straight away.
Targeted therapy and immunotherapy
Targeted therapies, such as bevacizumab, cetuximab and panitumumab, act on particular features of cancer cells and are mainly used with chemotherapy for advanced colorectal cancer. Whether they are likely to help depends on tests such as RAS and BRAF. Immunotherapy, which helps the immune system attack the cancer, works especially well for cancers with a DNA repair fault (dMMR or MSI-high). Ask whether these tests have been done on your cancer.
Clinical trials
Clinical trials are research studies that test whether a new treatment, a new combination of treatments or a new way of giving an existing treatment works better than current care. Many of today’s standard treatments were first offered through clinical trials.
What taking part involves
- Every trial has eligibility criteria, such as the type and stage of cancer, previous treatment and general health.
- Trials must be approved by a research ethics committee and, for medicines, by the national regulator. In Nigeria this includes NAFDAC and a recognised health research ethics committee.
- You will be given written information and asked for your informed consent before you join. You can ask questions at any time.
- Taking part is voluntary. You can leave a trial at any point and still receive standard care.
Finding a trial
Your treating team is the best place to start, because they know your diagnosis and which trials could suit you. Trial registries list studies that are recruiting:
- Pan African Clinical Trials Registry (PACTR): trials taking place in African countries.
- WHO International Clinical Trials Registry Platform: one search across registries worldwide.
- ClinicalTrials.gov: a large international registry run by the US National Library of Medicine.
Living with and after treatment
Side effects
Side effects depend on the treatment and usually improve once it ends. They may include:
- Tiredness, nausea, diarrhoea, mouth sores and a higher risk of infection during chemotherapy
- Tingling or numbness in the hands and feet with oxaliplatin, which can last for some time
- Diarrhoea, needing the toilet urgently and sore skin around the bottom during radiotherapy to the pelvis
- Changes in bowel habits after surgery, such as going more often or urgently, which often improve over months
- Changes to sexual function and fertility after pelvic surgery or radiotherapy. If you may want children in the future, ask about this before treatment starts
Living with a stoma
Learning to live with a stoma takes time, but most people return to work, family life, prayer, travel and exercise. A stoma nurse or trained health worker can show you how to empty and change your bag, look after the skin around the stoma and get supplies. Ask where you can get bags in your area and what to do if they are hard to find or afford.
- Eat regular meals and drink plenty of fluids. Your team can tell you whether any foods should be introduced slowly
- Watch the skin around the stoma and report soreness, bleeding, swelling or a stoma that changes colour
- Seek help quickly if no stool comes out for a long time and you have tummy pain or vomiting
It is normal to have strong feelings about a stoma. Talking with your care team, family or someone else who has a stoma can help.
Follow-up
After treatment you will have regular check-ups. These may include blood tests for CEA, CT scans and colonoscopy, to check for the cancer coming back and for new polyps. Report any new bleeding, change in bowel habits, tummy pain or weight loss in between appointments.
Your family
If you were diagnosed young, if several relatives have had colorectal or related cancers, or if your tests show a DNA repair fault, ask whether you should be checked for Lynch syndrome. Your close relatives may need earlier or more frequent screening.
Emotional support
A colorectal cancer diagnosis can affect body image, intimacy, work and finances, and bowel problems can be difficult to talk about. Talking with family, friends, your care team and other survivors can help.
Questions to ask your care team
- Where in the bowel is my cancer, what type is it and what stage is it?
- Has my cancer been tested for MMR or MSI, and for RAS and BRAF? What do the results mean?
- What are my treatment options, and what is the aim of each one?
- Will I need a stoma? If so, is it likely to be temporary or permanent, and who will help me look after it?
- How might treatment affect my bowel habits, sex life and fertility?
- What side effects should I expect, and who do I contact if I have them?
- Should my family members be screened, or should I be tested for an inherited condition?
- Is there a clinical trial that could be right for me?
